Advertisement
Gene therapy shows promise in treating recessive dystrophic epidermolysis bullosa

Gene Tx Promising in Recessive Dystrophic Epidermolysis Bullosa

0
Grafts of patients' genetically modified skin improved healing of wounds in early study

October 2016 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for October 2016. This roundup includes the latest...
In an non-integrated dermatopathology practice

Use of Term ‘Rule Out’ May Delay Dermatopathology Diagnosis

0
Use on requisition form linked to longer time to diagnosis, increased use of pathology stains, sections
For patients with moderate-to-severe seborrhea and seborrheic dermatitis

Low-Dose Isotretinoin Therapeutic for Seborrhea

0
Significant decrease in rate of sebum production in patients receiving low-dose oral isotretinoin
Private sector employer-sponsored health insurance offerings were similar in 2013 and 2014

Few Changes in Employer-Sponsored Insurance 2013-2014

0
Only 3.5 percent of employers dropped coverage and 1.1 percent added coverage from 2013 to 2014
In research published online Oct. 28 in Science Immunology

New Way Bacteria Can Trigger Inflammation in Acne Identified

0
Findings may lead to new avenues for treatment
In an article published in Medical Economics

Useful Tips Offered for Addressing Negative Patient Reviews

0
Doctors should respond quickly, validate patient complaints, demonstrate willingness to take action
For patients with cutaneous melanoma

Whites Have Longest Survival in Cutaneous Melanoma

0
For stages I and III, black patients have significantly lower survival, increased hazard ratios
Mohs micrographic surgery is efficacious for melanoma in situ (MIS) on the trunk and proximal extremities

Mohs Effective for Melanoma in Situ of Trunk, Extremities

0
Surgical margin of 9 mm needed to excise 97 percent of melanoma in situ
More than half of melanomas are self-detected

More Than Half of Melanomas Are Self-Detected

0
Self-detection by women ups prognosis; men have more melanomas in non-easily visible locations